300 related articles for article (PubMed ID: 33672324)
21. Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A.
Pajares M; Rojo AI; Arias E; Díaz-Carretero A; Cuervo AM; Cuadrado A
Autophagy; 2018; 14(8):1310-1322. PubMed ID: 29950142
[TBL] [Abstract][Full Text] [Related]
22. Impaired degradation of YAP1 and IL6ST by chaperone-mediated autophagy promotes proliferation and migration of normal and hepatocellular carcinoma cells.
Desideri E; Castelli S; Dorard C; Toifl S; Grazi GL; Ciriolo MR; Baccarini M
Autophagy; 2023 Jan; 19(1):152-162. PubMed ID: 35435804
[TBL] [Abstract][Full Text] [Related]
23. Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell Activity.
Auzmendi-Iriarte J; Otaegi-Ugartemendia M; Carrasco-Garcia E; Azkargorta M; Diaz A; Saenz-Antoñanzas A; Andermatten JA; Garcia-Puga M; Garcia I; Elua-Pinin A; Ruiz I; Sampron N; Elortza F; Cuervo AM; Matheu A
Cancer Res; 2022 Apr; 82(7):1283-1297. PubMed ID: 35131870
[TBL] [Abstract][Full Text] [Related]
24. Lighting chaperone-mediated autophagy (CMA) evolution with an ancient LAMP: the existence of a functional CMA activity in fish.
Herpin A; Lescat L; Bobe J; Jenny A; Seiliez I
Autophagy; 2020 Oct; 16(10):1918-1920. PubMed ID: 32772633
[TBL] [Abstract][Full Text] [Related]
25. Effects of Far-infrared Ray on Temozolomide-treated Glioma in Rats.
Chen JC; Hwang JH
In Vivo; 2019; 33(4):1203-1208. PubMed ID: 31280210
[TBL] [Abstract][Full Text] [Related]
26. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line.
Zhou Y; Wang HD; Zhu L; Cong ZX; Li N; Ji XJ; Pan H; Wang JW; Li WC
Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449
[TBL] [Abstract][Full Text] [Related]
28. Dysfunction of chaperone-mediated autophagy in human diseases.
Liao Z; Wang B; Liu W; Xu Q; Hou L; Song J; Guo Q; Li N
Mol Cell Biochem; 2021 Mar; 476(3):1439-1454. PubMed ID: 33389491
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide.
Lo Dico A; Martelli C; Diceglie C; Lucignani G; Ottobrini L
Front Oncol; 2018; 8():249. PubMed ID: 30013951
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
[TBL] [Abstract][Full Text] [Related]
31. Pros and Cons of Chaperone-Mediated Autophagy in Cancer Biology.
Arias E; Cuervo AM
Trends Endocrinol Metab; 2020 Jan; 31(1):53-66. PubMed ID: 31699565
[TBL] [Abstract][Full Text] [Related]
32. Long-lived mice with reduced growth hormone signaling have a constitutive upregulation of hepatic chaperone-mediated autophagy.
Endicott SJ; Boynton DN; Beckmann LJ; Miller RA
Autophagy; 2021 Mar; 17(3):612-625. PubMed ID: 32013718
[TBL] [Abstract][Full Text] [Related]
33. SNX10-mediated degradation of LAMP2A by NSAIDs inhibits chaperone-mediated autophagy and induces hepatic lipid accumulation.
Lee W; Kim HY; Choi YJ; Jung SH; Nam YA; Zhang Y; Yun SH; Chang TS; Lee BH
Theranostics; 2022; 12(5):2351-2369. PubMed ID: 35265214
[No Abstract] [Full Text] [Related]
34. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
Tomar MS; Kumar A; Srivastava C; Shrivastava A
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188616. PubMed ID: 34419533
[TBL] [Abstract][Full Text] [Related]
35. In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus.
Wang F; Tasset I; Cuervo AM; Muller S
Cells; 2020 Oct; 9(10):. PubMed ID: 33092174
[TBL] [Abstract][Full Text] [Related]
36. Chaperone-Mediated Autophagy in Neurodegenerative Diseases: Molecular Mechanisms and Pharmacological Opportunities.
Wang YT; Lu JH
Cells; 2022 Jul; 11(14):. PubMed ID: 35883693
[TBL] [Abstract][Full Text] [Related]
37. Chaperone-mediated autophagy dysregulation during aging impairs hepatic fatty acid oxidation via accumulation of NCoR1.
Choi YJ; Yun SH; Yu J; Mun Y; Lee W; Park CJ; Han BW; Lee BH
Mol Metab; 2023 Oct; 76():101784. PubMed ID: 37524243
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z
Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760
[TBL] [Abstract][Full Text] [Related]
39. LAMP2A, and other chaperone-mediated autophagy related proteins, do not decline with age in genetically heterogeneous UM-HET3 mice.
Zhang KK; Zhang P; Kodur A; Erturk I; Burns CM; Kenyon C; Miller RA; Endicott SJ
Aging (Albany NY); 2023 Jun; 15(11):4685-4698. PubMed ID: 37315291
[TBL] [Abstract][Full Text] [Related]
40. The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity.
Chen PH; Shen WL; Shih CM; Ho KH; Cheng CH; Lin CW; Lee CC; Liu AJ; Chen KC
Neuropharmacology; 2017 Apr; 116():300-314. PubMed ID: 27986595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
